文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

马拉维产ESBL肺炎克雷伯菌全基因组分析揭示多谱系获得多种ESBL决定因素

Genomic analysis of Klebsiella pneumoniae isolates from Malawi reveals acquisition of multiple ESBL determinants across diverse lineages.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

该研究对马拉维伊丽莎白女王中央医院收治患者中采集的72株侵袭性与携带性肺炎克雷伯菌分离株进行全基因组测序,并与肯尼亚66株及撒哈拉以南非洲以外67株已发表基因组比较。马拉维分离株分布于KpI、KpII和KpIII谱系,携带blaCTX-M-15、多种blaSHV、blaTEM-63和blaOXA-10等多种ESBL基因,未检出碳青霉烯类耐药基因,但检出与碳青霉烯耐药相关质粒pNDM-mar相似的IncFII和IncFIB质粒。

要点

  • 马拉维肺炎克雷伯菌多谱系携带多种ESBL基因,以blaCTX-M-15等为主。
  • 未检出碳青霉烯耐药基因,但存在可携带碳青霉烯耐药性的质粒。
  • 需快速采取干预措施,防止局部出现难以治疗的感染负担。

核心结论

  • 马拉维肺炎克雷伯菌在多样谱系中携带多种ESBL基因,且循环质粒具备携带碳青霉烯耐药性的能力,若不迅速干预可能导致脆弱人群出现高负担的局部难治性感染。

研究设计与样本

  • 对马拉维Queen Elizabeth Central Hospital收治患者中采集的72株侵袭性和携带性肺炎克雷伯菌分离株进行全基因组测序。
  • 对这些基因组及此前发表的肯尼亚66株和撒哈拉以南非洲以外67株基因组进行系统发育和种群结构分析。
  • 筛查抗菌药物耐药遗传决定因素,并按基因组序列簇、耐药表型和时间进行关联分析。

主要发现

  • 马拉维分离株符合肺炎克雷伯菌全球种群结构,聚类于KpI、KpII和KpIII主要谱系。
  • 马拉维KpI分离株与肯尼亚分离株亲缘更近,两地菌株比世界其他地区分离株表现出更强克隆性。
  • 在马拉维分离株的多样谱系中鉴定出多种ESBL基因,包括blaCTX-M-15、多种blaSHV、blaTEM-63和blaOXA-10,以及其他耐药基因。
  • 未检出碳青霉烯耐药基因,但检出与碳青霉烯耐药相关质粒pNDM-mar相似的IncFII和IncFIB质粒。
  • 原文未报告具体耐药比例、样本量之外的统计值或P值。

关键数值与推荐

  • 研究纳入马拉维分离株72株、肯尼亚66株、撒哈拉以南非洲以外67株基因组。
  • 检测到的ESBL基因包括blaCTX-M-15、多种blaSHV、blaTEM-63和blaOXA-10。
  • 未检出碳青霉烯耐药基因;检出与pNDM-mar相似的IncFII和IncFIB质粒。

临床怎么用

  • 对马拉维及类似资源有限地区产ESBL肺炎克雷伯菌感染,应关注多种ESBL基因和可移动质粒的传播风险。
  • 尽管当前未检出碳青霉烯耐药基因,但循环质粒可能介导碳青霉烯耐药性获得,需加强耐药监测和感染防控。
  • 应尽快实施适当干预措施,以降低脆弱人群局部难治性感染负担。

局限性

  • 原文未报告具体耐药比例、统计检验结果或P值。
  • 研究仅纳入马拉维单一医院分离株,样本量有限。
  • 原文未报告质粒接合转移实验等功能验证数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: ESBL-producing Klebsiella pneumoniae (KPN) pose a major threat to human health globally. We carried out a WGS study to understand the genetic background of ESBL-producing KPN in Malawi and place them in the context of other global isolates. METHODS: We sequenced genomes of 72 invasive and carriage KPN isolates collected from patients admitted to Queen Elizabeth Central Hospital, Blantyre, Malawi. We performed phylogenetic and population structure analyses on these and previously published genomes from Kenya (n = 66) and from outside sub-Saharan Africa (n = 67). We screened for presence of antimicrobial resistance (AMR) genetic determinants and carried out association analyses by genomic sequence cluster, AMR phenotype and time. RESULTS: Malawian isolates fit within the global population structure of KPN, clustering into the major lineages of KpI, KpII and KpIII. KpI isolates from Malawi were more related to those from Kenya, with both collections exhibiting more clonality than isolates from the rest of the world. We identified multiple ESBL genes, including blaCTX-M-15, several blaSHV, blaTEM-63 and blaOXA-10, and other AMR genes, across diverse lineages of the KPN isolates from Malawi. No carbapenem resistance genes were detected; however, we detected IncFII and IncFIB plasmids that were similar to the carbapenem resistance-associated plasmid pNDM-mar. CONCLUSIONS: There are multiple ESBL genes across diverse KPN lineages in Malawi and plasmids in circulation that are capable of carrying carbapenem resistance. Unless appropriate interventions are rapidly put in place, these may lead to a high burden of locally untreatable infection in vulnerable populations.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Musicha P, Msefula CL, Mather AE, et al. Genomic analysis of Klebsiella pneumoniae isolates from Malawi reveals acquisition of multiple ESBL determinants across diverse lineages. J Antimicrob Chemother. 2019. PMID: 30778540. doi:10.1093/jac/dkz032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。